Patents Assigned to International Center for Genetic Engineering and Biotechnology
  • Patent number: 6489105
    Abstract: The present invention relates to a screening method to identify individuals at risk of developing diseases associated with different polymorphic forms of wildtype p53; which comprises the steps of: a) obtaining a biological sample from said patients; and b) determining the presence of p53pro or p53arg wildtype alleles in said sample; wherein the allele pattern of patients selected from the group consisting of p53pro/p53pro, p53arg/p53arg and p53pro/p53arg are indicative of a risk factor for developing disease associated with different polymorphic forms of wildtype p53. Notably, individuals who are p53arg/arg are at greater risk of developing pathologies associated with human papillomavirus infections, including cervical cancer.
    Type: Grant
    Filed: March 1, 2000
    Date of Patent: December 3, 2002
    Assignees: McGill University, Imperial Cancer Research Technology, International Center for Genetic Engineering and Biotechnology
    Inventors: Greg J. Matlashewski, Lawrence Banks, Alan Storey